4/10
08:05 am
vrca
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $8.00 price target on the stock.
Low
Report
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $8.00 price target on the stock.
4/10
06:57 am
vrca
Rating for VRCA
Low
Report
Rating for VRCA
4/10
06:57 am
vrca
Rating for VRCA
Low
Report
Rating for VRCA
3/1
08:08 am
vrca
Rating for VRCA
Medium
Report
Rating for VRCA
3/1
08:08 am
vrca
Rating for VRCA
Medium
Report
Rating for VRCA